|
Since the discovery of the parasite responsible for Malaria in 1880, this disease has been the subject of intensive research and development within the academic and industrial sectors with a first patent filed as early as 1907 describing a quinine based treatment. Despite the small market (~1 billion $) generated by the drugs currently commercialized, more than 3000 patents describing new ways to control malaria were filed since 1980 with a growing interest over the last decade.
Next to a very dynamic institutional research, some industrials are marking out their position expecting increased reputation, but also with the hope of public and private funding and growing solvability of currently infected countries. New collab
orations are f
orming and companies emerge on very specific segments. With upcoming resistances, current challenges in controlling malaria consist in developing early rapid diagnostic tests, efficient and affordable preventive and curative drugs and vaccines but also in developing efficient insecticides and repellents. The R&D and patent strategy in this sector bring forth the interest of these three challenges.
In the current race for controlling malaria, this IP Overview provides you a comprehensive panorama of the intellectual property landscape and helps you:
- Position your company’s R&D and IP Portfolio
- Identify key invent
ors and key players involved in specific thematic
- Understand the collab
oration netw
orks and theirs dynamics
- Uncover trends and emerging segments
|
